Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - erysipelothrix rhusiopathiae; e. coli strain - o20:k88; e. coli strain - o149:k88; e. coli strain - o64:k99; e. coli strain - o9:987p; porcine parvo virus; formaldehyde; thiomersal - parenteral liquid/solution/suspension - erysipelothrix rhusiopathiae vaccine-general active 0.0 u; e. coli strain - o20:k88 vaccine-microbial active 0.0 u; e. coli strain - o149:k88 vaccine-microbial active 0.0 u; e. coli strain - o64:k99 vaccine-microbial active 0.0 u; e. coli strain - o9:987p vaccine-microbial active 0.0 u; porcine parvo virus vaccine-viral active 0.0 u; formaldehyde aldehyde other 1.2 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pig - piglet | pigs | boar | gilt | neonatal piglet | new born pig | piglet | sow | sucker pig | swine - erysipelas infection | escherichia coli scours | leptospirosis - leptospira pomona | parvovirus | l. interrogans serovar pomona | leptospira pomona infection | white scours

Europos Sąjunga - anglų - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared from a/vietnam/1194/2004 nibrg-14 (h5n1) (see section 5.1).prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals 3.75 µg should be used in accordance with official guidance.

Europos Sąjunga - anglų - EMA (European Medicines Agency)

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccines - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.

Airija - anglų - HPRA (Health Products Regulatory Authority)

intervet ireland limited - f11-antigen suspension, ft-antigen suspension - emulsion for injection - %v/v - escherichia vaccine - fowl - chicken - immunological - inactivated vaccine

Airija - anglų - HPRA (Health Products Regulatory Authority)

intervet ireland limited - f11-antigen (containing 100 µg f11); ft-antigen (containing 100 µg ft) - emulsion for injection - . - escherichia - chickens - immunological - inactivated vaccine

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - inactivated salmonella dublin & typhimurium antigens; thiomersal - misc. vaccines or anti sera - inactivated salmonella dublin & typhimurium antigens vaccine-microbial active 0.0 undefined; thiomersal mercury other 0.1 mg/ml - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - salmonella | including b-lactamase producin | salmonellosis

Europos Sąjunga - anglų - EMA (European Medicines Agency)

zoetis belgium sa - inactivated bluetongue virus, serotype 1, strain btv-1/alg2006/01, inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02 - bluetongue virus, sheep, inactivated viral vaccines - sheep - active immunisation of sheep from 1.5 months of age to prevent viraemia caused by bluetongue virus, serotypes 1 and 8.onset of immunity: 21 days after completion of the primary vaccination scheme.duration of immunity: 12 months.

Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi pasteur europe s.a. - rabies virus (inactivated) ; albumin human 50 mg - powder and solvent for solution for injection - rabies virus, inactivated - rabies, inactivated, whole virus

Malaizija - anglų - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga lifescience sdn. bhd. - inactivated sars-cov-2 virus (cz02 strain) (vero cell) -

Malaizija - anglų - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga lifescience sdn. bhd. - inactivated sars-cov-2 virus (cz02 strain) (vero cell) -